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Abstract
Background: Many susceptible loci for type 2 diabetes mellitus (T2DM) have recently been identified from Caucasians
through genome wide association studies (GWAS). We aimed to determine the association of 11 known loci with T2DM and
impaired glucose regulation (IGR), individually and in combination, in Chinese.
Methods/Principal Findings: Subjects were enrolled in: (1) a case-control study including 1825 subjects with T2DM, 1487
with IGR and 2200 with normal glucose regulation; and (2) a prospective cohort with 734 non-diabetic subjects at baseline.
The latter was followed up for 3.5 years, in which 67 subjects developed T2DM. Nineteen single nucleotide polymorphisms
(SNPs) were selected to replicate in both studies. We found that CDKAL1 (rs7756992), SLC30A8 (rs13266634, rs2466293),
CDKN2A/2B (rs10811661) and KCNQ1 (rs2237892) were associated with T2DM with odds ratio from 1.21 to 1.35. In the
prospective study, the fourth quartile of risk scores based on the combined effects of the risk alleles had 3.05 folds (95% CI,
1.31–7.12) higher risk for incident T2DM as compared with the first quartile, after adjustment for age, gender, body mass
index and diabetes family history. This combined effect was confirmed in the case-control study after the same adjustments.
The addition of the risk scores to the model of clinical risk factors modestly improved discrimination for T2DM by 1.6% in
the case-control study and 2.9% in the prospective study.
Conclusions/Significance: Our study provided further evidence for these GWAS derived SNPs as the genetic susceptible loci
for T2DM in Chinese and extended this association to IGR.
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Introduction
Type 2 diabetes mellitus (T2DM) is one of the fastest growing
diseases with a major impact on morbidity and premature
mortality worldwide. A rapid increase in the prevalence of
T2DM and impaired glucose regulation (IGR) has also been
observed in China in recent decades [1]. T2DM is a complex
disorder characterized by impaired insulin sensitivity and
pancreatic b cell dysfunction; and is involved in complicated
interactions between genetic variants and environmental factors.
Multiple genes have been found involving in the pathogenesis of
T2DM. Recently, several genome wide association studies
(GWAS) and replicated studies on the common genetic variants
in T2DM have been reported in several large white populations
[2–5] since the first GWAS [6] published. Several new candidate
genes (TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/2B,
IGF2BP2, KCNQ1, etc.) have been identified in relation to an
increased risk for T2DM. Some studies have implicated that the
genetic polymorphisms may be involved in the process of insulin
production and/or secretion [4,7,8].
IGR includes impaired fasting glucose (IFG) and/or impaired
glucose tolerance (IGT). IGR is also known as intermediate
hyperglycemia or pre-diabetes and characterized by high blood
glucose concentrations, insulin resistance and impaired insulin
secretion. Previous studies have shown that 5210% IGT subjects
developed diabetes each year, although, some of them could revert
spontaneously to normal glucose tolerance [9,10]. It would be
worthwhile to determine whether the common genetic variations
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14022play any role in the pathogenesis of IGR and whether IGR shared
the same risk genetic background with T2DM [11,12].
Despite a moderate effect of individual genetic factors on
T2DM and a premature testing for inherited susceptibility based
on common risk alleles, the genetic assessment for persons at high
risk for T2DM has received much consideration [13]. It is
important to understand whether a combination of the major
genetic factors would contribute more to T2DM or may be used to
stratify high-risk populations [14–18].
Given the differences in genetic background (ethnics, geograph-
ic ancestries, linkage disequilibrium pattern and risk allele
frequencies) [19] and risk factor profiles (body composition and
insulin secretion/resistance patterns), it is necessary to replicate the
genetic association study in Chinese population to clarify the roles
in those susceptible genes. In the present study, we aimed to verify
the associations of 19 single nucleotide polymorphisms (SNPs) in
11 genes (PPARG, IGF2BP2, CDKAL1, SLC30A8, CDKN2A/2B,
HHEX, EXT2, KCNJ11, KCNQ1, MTNR1B and TCF2) with the
risk of T2DM and IGR in Chinese population; and followed by
the investigation of the combined effect of these genes on the risk
of T2DM in both case-control study and prospective cohort.
Methods
Ethics statement
This study was approved by the Institutional Review Board of
the Ruijin Hospital, Shanghai Jiao Tong University School of
Medicine and was in accordance with the principle of the Helsinki
Declaration II. The written informed consent was obtained from
each participant.
Study population
Case-control study: The participants were recruited from an
ongoing glucose survey in Baoshan District of Shanghai during
2004 to 2008. The study population, design and protocols of this
case-control study have been previously described [20,21]. In
brief, we first invited all registered permanent residents aged 40 or
above by poster advertisement and by mail to participate in a
screening examination. We then collected information on lifestyle,
medical history and the use of medications using a questionnaire,
performed anthropometrical measurements and 75-g oral glucose
tolerance tests (OGTT), and blood and urine sampling. Eventu-
ally, we enrolled 5012 subjects who have finished OGTT in the
genetic study, which included 2200 subjects with normal glucose
regulation (NGR, 844 males and 1356 females), 1478 subjects with
IGR (595 males and 892 females) and 1825 T2DM patients (802
males, 1023 females).
Prospective study: Nine hundred and forty-four non-diabetic
individuals determined at baseline in 2005 in the Baoshan District
were invited to participate in the follow-up examination in 2008.
After excluding the subjects with neither DNA samples (n=190)
nor information of glucose metabolism status (n=20) available,
the remaining 734 subjects were selected for the genetic analysis.
Clinical examination and biochemical analysis
Individual height, weight, and waist and hip circumferences
were measured by the experienced physicians. Blood pressure was
measured at non-dominant arm in a seated position after a ten-
min rest using an automated electronic device (OMRON Model1
Plus, Japan). Three measurements were taken in one min apart
and an average of the three was used in analysis. The fasting and
2-h OGTT plasma glucose, serum triglycerides, total cholesterol,
high-density lipoprotein and low-density lipoprotein cholesterol
were determined using an automated biochemical instrument
(Beckman CX-7 Biochemical Autoanalyser, Brea, CA, USA).
Fasting serum insulin was measured by radioimmunoassay
(Sangon Company, Shanghai, China).
Definitions
IGR was defined as IFG (Fasting plasma glucose $5.6 mmol/l
and ,7.0 mmol/l) and/or IGT (2-h OGTT plasma glucose $7.8
and ,11.1 mmol/l). T2DM was diagnosed at fasting plasma
glucose $7.0 mmol/l and/or 2-h OGTT plasma glucose level
$11.1 mmol/l and/or treatment with antidiabetic medication
(oral agents or insulin injection). A fasting plasma glucose level less
than 5.6 mmol/l and a 2-h OGTT plasma glucose level less than
7.8 mmol/l were defined as NGR. The insulin resistance index of
the homeostasis model assessment (HOMA-IR) was calculated as
fasting plasma insulin (in milliunits per milliliter) 6fasting plasma
glucose (in millimoles per liter)/22.5 and b-cell function (HOMA-
b) was assessed as fasting plasma insulin (in milliunits per milliliter)
620/(fasting plasma glucose - 3.5) (in millimoles per liter).
Candidate loci and genotyping
We selected 17 common SNPs from 9 loci that had a nominal to
strong association with T2DM in recently published GWAS
including: IGF2BP2 (rs1470579 and rs4402960), CDKAL1
(rs7756992), SLC30A8 (rs13266634 and rs2466293), CDKN2A/2B
(rs564398 and rs10811661), HHEX (rs7923837, rs1111875 and
rs5015480), EXT2 (rs1113132, rs11037909 and rs3740878),
KCNQ1 (rs2237892), MTNR1B (rs10830963 and rs1387153) and
TCF2 (rs7501939) [2–6,22–25]. We also included other 2 loci,
PPARG (rs1801282) and KCNJ11 (rs5215) in genotyping, which
had been validated as candidate genes for T2DM. We did not
include the loci of JAZF1, CDC123-CAMK1D, TSPAN8-LGR5,
THADA, ADAMTS9 and NOTCH2, which were reported from a
meta-analysis [26]. TCF7L2 (rs12255372, rs7901695, rs7903146
or rs11196205), and WFS1 (rs6446482, rs10010131) loci were
excluded since their minor allele frequencies are less than 5% in
Han Chinese according to the HapMap CHB group (http://snp.
cshl.org/cgi-perl/gbrowse/hapmap22_B36/). Exclusion also con-
tains the FTO loci (rs8050136, rs9939609, rs9930506) since no
association of this locus with T2DM has been demonstrated in
Chinese [27].
Genomic DNA was extracted from peripheral blood leukocytes
with standard phenol/chloroform-based method. All the selected
SNPs were genotyped by SNaPshotH Multiplex System (Applied
Systems) following the manufacture’s protocol. In our study, the
call rate was ranged from 94% (rs2466293) to 99% (rs3740878) in
the case-control study, and from 97% (rs1801282) to 99%
(rs564398) in the prospective cohort. There is no significant
difference of SNP calling between the case and the control groups.
The average consensus rate in the duplicate samples (n=256) was
99.7%, and all the SNPs were in accordance with Hardy-
Weinberg equilibrium (all P$0.01, Table S1).
Risk score
The risk score was calculated on the basis of SNPs that were
significantly associated with T2DM in the present case-control
study. We assumed the additive genetic model [28] for each SNP,
applying a linear weighing of 0, 1, and 2 to genotypes containing
0, 1, or 2 risk alleles, respectively. Three logistic regression models
with different adjustments were used to investigate effect of risk
scores on T2DM and IGR in the case-control analysis and on
incident diabetes in the prospective analysis, respectively. Multi-
plicative interactions between conventional risk factors and the risk
scores were tested using the likelihood ratio test. To measure the
discriminative improvement attributable to the risk score, we
Genetic Risk of T2DM
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logistic regression model including conventional risk factors and a
model including conventional risk factors and the genetic risk score
[29]. The conventional model included age (continuous), gender,
family history of diabetes (yes or no) and BMI (continuous).
Statistical analysis
Deviation from Hardy-Weinberg equilibrium for genotypes at
individual locus was assessed using the Chi-square test. A
multiple logistic regression model was used to investigate the
individual effect of these genes on IGR and T2DM. These
analyses were based on additive, recessive and dominant models,
and adjusted for age, gender and BMI. The statistical analyses
were performed using SAS version 8.1 (SAS Institute, Cary, NC).
In order to avoid any potential spurious result in our association
replications, the most conservative Bonferroni correction was
used to ensure a high stringent condition for any positive result.
P,0.0026 (0.05 divided by 19, the total number of SNPs studied)
was considered significant. LD estimation of the SNPs was
obtained using Haploview version 3.32 (http://www.broad.mit.
edu/mpg/haploview/). Current sample size, minor allele
frequencies observed in the present study and the previously
reported odds ratios (ORs) for T2DM was used for statistical
power estimation (Table S1).
Results
The clinical characteristics of the study subjects
The case-control study had a total of 5512 subjects, including
2200 subjects (39.9%) with NGR, 1487 (27.0%) with IGR and
1825 (33.1%) T2DM patients. The characteristics of the
participants were shown in Table 1.
In the prospective study, of the 734 non-diabetic subjects at
baseline, 67 subjects turned to T2DM in 3.5 years. The clinical
characteristics of the prospective study subjects were shown in
Table S2.
Individual effects of polymorphisms on IGR and T2DM
The case-control study. The characteristics of the 19 risk
loci and their associations with IGR and T2DM were shown in
Table 2. Three heredity models (additive, recessive or dominant)
were introduced to study the associations between the SNPs and
IGR or T2DM. SNPs rs10811661 (CDKN2A/2B) and rs2466293
(SLC30A8) were associated with increased risk in both IGR and
T2DM. SNP rs7756992 (CDKAL1) was associated with T2DM,
but not IGR. SNPs rs13266634 (SLC30A8) and rs2237892
(KCNQ1) were nominally associated with IGR and statistically
significantly associated with T2DM (P,00001); whereas, two
SNPs rs1470579 and rs4402960 (IGF2BP2), and two SNPs rs5215
(KCNJ11) and rs7501939 (TCF2) were nominally associated with
T2DM. SNPs rs1111875 (HHEX) and rs10830963 (MTNR1B)
were only associated with the risk of IGR, not T2DM. All the
analysis was based on the adjustment for age, gender and BMI.
The prospective study. The genotype frequencies and
individual risk for incident diabetes were shown in Table 3. The
risk allele of SNPs rs10811661 (CDKN2A/2B), rs13266634
(SLC30A8) and rs2466293 (SLC30A8) increased the risk of
incident T2DM by 94%, 88% and 152%, respectively, in the
recessive model after adjustment for the effect of age, gender and
BMI. The risk allele C of rs1387153 (MTNR1B) was associated
with the increased risk of T2DM by 85% in the dominant model.
Genetic risk score and risk of type 2 diabetes
The risk score was calculated based on SNPs rs7756992
(CDKAL1), rs2466293 (SLC30A8), rs10811661 (CDKN2A/2B) and
rs2237892 (KCNQ1), which were statistically significantly associat-
ed T2DM in the case-control study. The risk score was calculated
by summing up the number of risk alleles for each participant who
had the genotyping information of these 4 SNPs (534 participants
were excluded from calculation because of incomplete genotype
information). We included SNP rs2466293 of SLC30A8 to
calculate the risk score since it was reported to be associated with
T2DM in Chinese in our previous study [30] and the correlation
Table 1. Characteristics of the participants in the case-control study.
The case-control sample set (n=5512)
NGR IGR T2DM P*
Male/Female, n (M, %) 844/1356 (38.4) 595/892 (40.0) 802/1023 (43.9) ,0.0001
Age (years) 59.369.6 61.069.4 63.369.7 ,0.0001
Body mass index (kg/m
2)2 4 . 3 63.3 25.563.4 26.363.8 ,0.0001
Systolic blood pressure (mmHg) 131620 140622 147622 ,0.0001
Diastolic blood pressure (mmHg) 77610 80610 81611 ,0.0001
Fasting plasma glucose (mmol/l) 4.960.5 5.560.6 7.762.5 ,0.0001
OGTT-2h plasma glucose (mmol/l) 6.061.1 8.361.5 16.165.2 ,0.0001
Fasting serum insulin (mU/ml) 4.3 (4.0–4.7) 5.0 (4.6–5.4) 6.4 (5.9–6.9) ,0.0001
HOMA_IR (%) 1.17 (0.73–1.76) 1.74 (1.03–2.69) 2.88 (1.72–4.84) ,0.0001
HOMA_b (%) 82.1
(51.7–124.9)
74.4
(43.1–123.5)
50.2
(25.3–90.6)
,0.0001
Current smoking, yes, n (%) 465 (21.1) 276 (18.6) 385 (22.7) 0.01
Current alcohol intake, yes, n (%) 353 (16.9) 239 (16.2) 299 (18.4) 0.06
Diabetes family history, yes, n (%) 258 (12.3) 226 (15.4) 430 (25.3) ,0.0001
Data are means 6 SD or median (interquartile) or number (percentage).
*Based on ANOVA for continuous variables and x
2 for categorical variables. HOMA_IR, homeostasis model assessment of insulin resistance; and HOMA_b, homeostasis
model assessment of b-cell function.
doi:10.1371/journal.pone.0014022.t001
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squared =0.49) (Table S3). The risk scores were significantly
higher in T2DM and IGR than that in NGR. The mean risk
scores for T2DM, IGR and NGR were 4.45, 4.24 and 3.99,
respectively (P,0.0001) after adjustment for age, gender, BMI,
diabetes family history, current smoking and alcohol intake in the
case-control analysis. Similarly, the mean risk score was 4.81 for
the incident diabetic patients and 4.33 for the non-diabetics in the
prospective study, and the difference reached statistical significant
(P=0.02), after the adjustment for the same factors as above.
The subjects with T2DM or IGR had more risk alleles than
those with NGR (both P#0.0003) (Figure 1A). Also, the T2DM
incidence was increased significantly along with the increased
number of risk alleles (Figure 1B).
In the case-control study, we performed the logistic regression
analysis for the association between the risk scores and T2DM and
IGR in both continuous and category patterns (Table 4).
Compared with the first quartile of risk scores, the fourth quartile
has 1.53 and 2.29 folds higher risk of IGR and T2DM,
respectively, after adjustment for age, gender, BMI, current
smoking, alcohol intake (Model 2). The category analysis, in which
the risk score was classified by quartiles (0–3, 4, 5, 6–8) yielded
similar results (Table 4). Furthermore, possible interactions
between genetic risk scores and the clinical risk factors in the
case-control association study were explored in stratified analysis
and by adding interaction terms to logistic regression models
(Table S4). We stratified the study subjects by quartiles of BMI
(#22.9, 23.0–25.0, 25.1–27.4, $27.5), quartiles of HOMA_b
(#39.1, 39.2–69.4, 69.5–114.6, $114.7) and family history (yes or
no). The P values for interaction were shown in Table S4. In each
of the stratification, the increased risk score was associated with the
prevalence of T2DM (all P for trend,0.05, Table S4).
In the prospective study, the same models were introduced
(Table 5). The fourth quartile of risk scores had 3.05 folds (95%
CI, 1.31–7.12) higher risk for incident T2DM as compared with
the first quartile, after adjustment for age, gender, BMI, diabetes
family history, current smoking and alcohol intake (Model 2,
Table 5).
Discriminative improvement attributable to the risk score
The combined effect of genetic and clinical risk factors on
T2DM was shown in Figure. 2. The area under ROC was 0.714
for clinical risk factors alone and 0.730 for combined genetic risk
score and clinical risk factors (both P,0.0001). Thus, the
combined effect was only increased by 1.6% as compared with
clinical factors in the case-control study (Figure 2A). In the
prospective study, the discriminative improvement for incidence of
T2DM by combining the genetic risk score was increased by 2.9%
as compared with clinical factors alone (Figure 2B, the area under
ROC was 0.634 for clinical factors and 0.663 for combined risk
factors, P=0.002 and ,0.0001, respectively).
Discussion
In our present study, the findings support the individual
associations of CDKN2A/2B (rs10811661), SLC30A8 (rs13266634
and rs2466293), CDKAL1 (rs7756992) and KCNQ1 (rs2237892)
with not only T2DM but also IGR in a case-control study. We also
confirmed the predictive effect of CDKN2A/2B (rs10811661),
SLC30A8 (rs13266634 and rs2466293) on the incident T2DM in
the 3.5 year follow-up study. Furthermore, we found that the
combination of the risk alleles demonstrated a more robust
association with T2DM and IGR than a single one after
adjustment for the common clinical risk factors, such as age,
gender, BMI and diabetes family history in both case-control and
prospective studies. The combined genetic risk scores only had a
discriminative improvement of 2.9% for incidence of T2DM as
compared with clinical risk factors alone.
We observed a significant association between T2DM and
SLC30A8 (rs13266634 and rs2466293) and CDKN2A/2B
(rs10811661) in not only the case-control study but also the
prospective study. These findings were consistent with what have
been observed in a large sample-size Caucasian population in
Denmark [31] and several populations in Asia [30,32–34].
Recently, we have verified that SLC30A8 gene is a susceptible
locus for T2DM in Chinese population [30]. We confirmed the
rs13266634 was associated with T2DM and reported that
rs2466293 (one of the tagger SNPs of SLC30A8) was nominally
associated with T2DM. Moreover, SNP rs13266634 is correlated
with glucose-stimulated insulin secretion. A similar observation is
also confirmed in a Japanese population [32]. In a case-control
Figure 1. Distribution of the genetic risk score and different
glucose metabolism status. Panel A, the case-control study. The
percentage of different glucose metabolism status according to the
number of risk alleles. P values were calculated by Chi-square analysis.
Panel B, the prospective study. The percentage of incident T2DM and
remaining non-diabetes according to the risk score. The numbers above
the bars are the subjects with the corresponding risk score. With per 1
risk allele increasing, the risk for incident T2DM increases by 33%
(P=0.007), after adjusted for age, gender, BMI, diabetes family history,
current smoking and alcohol intake.
doi:10.1371/journal.pone.0014022.g001
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Hong Kong and two Korean cohorts, these candidate genes have
critical contribution to T2DM as compared with Caucasians [33].
Functional studies [35,36] found that zinc transporter 8 (ZnT8) is
required for normal insulin crystallization and insulin processing
and secretion. The R allele of rs13266634 (W325R) may increase
T2DM risks [35]. Further studies which focus on small molecule
activators that target ZnT8 may thus represent an interesting
means to treat insulin secretary deficiency in T2DM.
SNP rs10811661 is located at 125 kilo-bases upstream of the
CDKN2A/2B gene. Given the prior knowledge on SNP function,
we assumed that SNP rs10811661 might exert its effect on
transcription directly or indirectly through an unknown locus
which have high LD with this variant. The CDKN2A/2B genes are
expressed in adipocytes and pancreatic islets [6]. CDKN2A/2B
encodes for p16INK4a, a tumor suppressor influencing pancreatic
b-cell proliferation [37,38].It is possible for a causal variant
situated in CDKN2A/2B to increase the susceptibility of T2DM
through b-cell mass reduction and subsequent insulin release
impairment in the sates with increased insulin demand.
KCNQ1 gene was believed to be a confirmed risk loci for T2DM
in Chinese [39,40]. In the present study, we confirmed that SNPs
rs2237892 in KCNQ1 was in relation to T2DM and IGR with the
odds ratio of 1.35 and 1.17 respectively in the case-control
analysis, but not in the prospective study. The predictive effect of
KCNQ1 gene for incident diabetes and the potential mechanism of
this gene in the pathogenesis of T2DM remain to be explored.
We found some evidence of combined effect of those risk alleles
on T2DM in both case-control and prospective studies. These
results are consistent with those reported by Scott et al. [3] and
other groups [14–18]. In Scott’s study, they examined the
combined effect of ten risk variants in a GWAS of Europeans,
in which they found a fourfold variation in T2DM risk from the
lowest to highest predicted risk groups. However, they pointed out
that the predictions based on their data might be biased owing to a
likely overestimation of ORs because of enrichment for familial
T2DM and exclusion of individuals with impaired glucose
tolerance or impaired fasting glucose. The risk score in our study
improved case–control discrimination beyond what the clinical
risk factors could provide, but the magnitude of this improvement
was small. This was consistent with other studies performed in
prospective populations that provided the joint effect of multiple
risk loci and the combined prediction on incident T2DM [14–18].
Lyssenko et al. [16] suggested that the addition of genotyping data
from the known DNA variants to clinical risk factors, including a
family history of diabetes, had a minimal, albeit statistically
significant effect on the prediction of future T2DM and the
assessment of genetic risk factors is more meaningful in the early
Table 4. The risk of impaired glucose regulation and type 2 diabetes in relation to gene risk scores.
Impaired glucose regulation P1 for trend Type 2 diabetes P2 for trend
Cross-sectional
Continuous, per 1 risk score
Model 1 1.13 (1.08–1.20) ,0.0001 1.26 (1.20–1.33) ,0.0001
Model 2 1.18 (1.11–1.25) ,0.0001 1.28 (1.21–1.35) ,0.0001
Classed by quartiles of the risk score
Model 1 Q1 0–3 1 0.0002 1 ,0.0001
Q2 4 1.22 (1.01–1.47) 1.44 (1.20–1.73)
Q3 5 1.38 (1.13–1.68) 2.08 (1.72–2.50)
Q4 6–8 1.57 (1.26–1.95) 2.24 (1.83–2.75)
Model 2 Q1 0–3 1 0.0003 1 ,0.0001
Q2 4 1.25 (1.03–1.52) 1.51 (1.23–1.84)
Q3 5 1.45 (1.18–1.78) 2.23 (1.82–2.74)
Q4 6–8 1.53 (1.22–1.92) 2.29 (1.83–2.86)
Values are odds ratio (95% confidence interval). P1 for trend value, for the risk of impaired glucose regulation, we defined participants with normal glucose regulation as 0
and impaired glucose regulation as 1, not including type 2 diabetic patients in the analysis; while P2 for trend value, for the risk of type 2 diabetes, we defined normal
glucose regulation as 0 and type 2 diabetes as 1. Q1, quartile 1; Q2, quartile 2; Q3, quartile 3; Q4 quartile 4.
Model 1, unadjusted;
Model 2, adjusted for age, gender BMI, diabetes family history, current smoking and alcohol intake.
doi:10.1371/journal.pone.0014022.t004
Table 5. The predictive effect of the risk score on incident
diabetes in the prospective study.
Model 1 Model 2
Continuous, per 1 risk score
ORs 1.32 (1.07–1.63) 1.33 (1.08–1.68)
P1 for trend 0.009 0.007
Classed by quartiles of the risk score
Q1 (0–3) 1 1
Q2 (4) 1.67 (0.67–3.94) 1.60 (0.66–3.88)
Q3 (5) 1.07 (0.40–2.87) 1.20 (0.44–3.27)
Q4 (6–8) 2.98 (1.30–6.83) 3.05 (1.31–7.12)
P2 for trend 0.02 0.03
Values are odds ratio (95% confidence interval). P for trend values, for the risk of
incident type 2 diabetes, we defined subjects remaining non-diabetic as 0 and
the incident type 2 diabetes as 1. Q1, quartile 1; Q2, quartile 2; Q3, quartile 3; Q4
quartile 4.
Model 1, unadjusted;
Model 2, adjusted for age, gender BMI, diabetes family history, current smoking
and alcohol intake.
doi:10.1371/journal.pone.0014022.t005
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e14022Figure 2. Discriminative improvements attributable to the risk score. Panel A, the case-control study. The combined effect of genetic risk
score and clinical factors on T2DM increased by 1.6% compared to clinical factors. The area under ROC was 0.714 for clinical factors and 0.730 for
combined risk score and clinical factors (both P,0.0001). Panel B, the prospective study. The discriminative improvement for incident T2DM by
combining the genetic risk score was 2.9% compared with clinical factors (the area under ROC was 0.634 for clinical factors and 0.663 for combined
risk factors, P=0.002 and ,0.0001, respectively). The black line represented the combined effect of clinical factors and risk score, and the dotted line
was the effect of clinical factors. The clinical factors included age (continuous), gender, family history of diabetes (yes or no) and BMI (continuous).
The risk score was categorized as quartiles.
doi:10.1371/journal.pone.0014022.g002
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would be more convinced to affirm whether combinations of risk
alleles from these variants provide a better predictive and
diagnostic potential in Chinese.
We included subjects with IGR (impaired fasting glucose and
impaired glucose tolerance) in the present study. Few studies were
concerned about the association of these GWAS variations with
IGR [11]. IFG and/or IGT were predisposed to diabetes;
however, whether the IGR and T2DM shared the same spectrum
of genetic variations is not well characterized. Here in our study,
we found that majority of the SNPs that are associated with
T2DM was also conferred the risk of IGR. Our study provided
evidence that IGR might have similar background of susceptible
genetic variations. However, because the IGR included IFG and
IGT which may have different genetic etiology [41,42], more
prospectively-designed association studies with large sample size
and more SNPs included are needed in the near future.
Our present study has strength and limitation to be addressed.
The main strength of the present study was that we explored the
combining effect of those susceptible genes in both a case-control
study with a moderate sample size and a 3.5-year follow-up study.
We speculated that the joint effect of the genetic variations, which
were validated in our study, provided a more strong association
with risk of T2DM and IGR. This study extended the knowledge
about the genetic factors and the pathogenesis of T2DM beyond
the Caucasian population. There are some limitations that should
be addressed in this study. The sample size for the prospective
study was relatively small and the cases of incident T2DM were
limited. Only two of the SNPs that were found to be significantly
associated with T2DM in the case-control analysis were validated
in the prospective study.
In conclusion, our study affirmed the associations of SNPs in
CDKN2A/2B, SLC30A8, KCNQ1, and CDKAL1 genes with the risk
of IGR and T2DM in a case-control study; and stronger
associations were found when the risk alleles combined. Our
study provided the further evidence of that these GWAS derived
genetic susceptible variations are also important for T2DM in
Chinese and extended the association of these variations with
IGR.
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